- 데이터 없음
한국어
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Researchers have developed a new experimental platform that can measure the light wave electric field captured between two mirrors with sub periodic accuracy. This electro-optical Fabry Perot resonant cavity will achieve precise control and observation of the interaction between light and matter, especially in the terahertz (THz) spectral range. The research results were published in the journal "...
In a groundbreaking scientific study published in Volume 13 of the Scientific Report, researchers reported on the results of Young's double slit interference experiment using oscillating vortex radiation under a photon counting system. The experiment involves using a spiral oscillator to emit second harmonic radiation in the ultraviolet range. Using an ultra narrow bandpass filter in the low curre...
Recently, the German research institution Fraunhofer ILT team is collaborating with the Department of Optical Systems Technology (TOS) at RWTH Aachen University to develop a testing system aimed at studying complex laser beam profiles using a new platform. This platform can construct customized beam profiles for laser powder melting (PBF-LB) 3D printing, thereby improving part quality, process sta...
Recently, the team led by Professor Li Zhiyuan from South China University of Technology has successfully developed a full spectrum white light laser, which has the characteristics of bright spot, smooth and flat spectrum, and large pulse energy. It can cover the ultraviolet visible infrared full spectrum of 300-5000nm, with a single pulse energy of 0.54mJ.The launch of such a full spectrum white ...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...